BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6088369)

  • 1. Circulating antibodies against human chorionic gonadotropin following trophoblastic disease.
    de Bruijn HW; Groenhuis A; Aalders JG
    Gynecol Oncol; 1984 Sep; 19(1):114-9. PubMed ID: 6088369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific binding proteins for human chorionic gonadotrophin in a patient with trophoblastic disease.
    Chan DW; Bill MJ; Rosenshein N
    Am J Clin Pathol; 1981 Aug; 76(2):214-6. PubMed ID: 6267931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to human chorionic gonadotropin in humans.
    Musch K; Wolf AS; Lauritzen C
    Clin Chim Acta; 1981 Jun; 113(1):95-100. PubMed ID: 6263525
    [No Abstract]   [Full Text] [Related]  

  • 4. Application of the radioreceptor assay for human chorionic gonadotropin in pregnancy testing and management of trophoblastic disease.
    Boyko WL; Russell HT
    Obstet Gynecol; 1977 Sep; 50(3):324-32. PubMed ID: 197458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal versus polyclonal antibody radioimmunoassay against the beta-subunit of human chorionic gonadotropin in patients with gestational trophoblastic neoplasia.
    Wu T; Ballon SC; Teng NN
    Am J Obstet Gynecol; 1983 Dec; 147(7):821-5. PubMed ID: 6196974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of trophoblastic neoplasia at the Cancer Control Agency of British Columbia.
    Boyes DA; Pankratz E; Galliford B; White GM; Fairey RN; Yuen BH
    Can Med Assoc J; 1977 Oct; 117(7):753-6. PubMed ID: 198082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Restoration of the equilibrium of secretion of gonadotropic hormones of the pituitary gland after the disappearance of HCG as an objective indicator of the effectiveness of chemotherapy of uterine trophoblastic tumors].
    Lomonosova MV; Savinskaia AP; Kozachenko VP
    Akush Ginekol (Mosk); 1984 Nov; (11):49-52. PubMed ID: 6098187
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen.
    Dgani R; Zalel Y; Biran H; Blickstein I; Caspi B; Weissman A; Shoham Z
    Eur J Obstet Gynecol Reprod Biol; 1994 Mar; 54(1):77-9. PubMed ID: 7519153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved monitoring of gestational trophoblastic neoplasia using a highly sensitive assay for urinary human chorionic gonadotropin.
    Wehmann RE; Ayala AR; Birken S; Canfield RE; Nisula BC
    Am J Obstet Gynecol; 1981 Aug; 140(7):753-7. PubMed ID: 6266253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
    McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
    J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease.
    Pezeshki M; Hancock BW; Silcocks P; Everard JE; Coleman J; Gillespie AM; Tidy J; Coleman RE
    Gynecol Oncol; 2004 Dec; 95(3):423-9. PubMed ID: 15581942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the indication of surgical resection of pulmonary metastasis of malignant trophoblastic tumor].
    Zhang Y; Xiang Y; Ren T; Wan XR; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):83-6. PubMed ID: 15840284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
    Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
    J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worldwide controversies in gestational trophoblastic neoplasms.
    Goldstein DP
    Int J Gynaecol Obstet; 1977; 15(3):207-15. PubMed ID: 205453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours.
    Begent RH; Chester KA; Walker LC; Tucker DF
    Br J Cancer; 1982 Feb; 45(2):217-22. PubMed ID: 6174138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Course of pregnancy and labor following cytostatic treatment of trophoblastic tumors].
    Richter P; Buchholz K; Lotze W
    Zentralbl Gynakol; 1987; 109(9):586-9. PubMed ID: 3039759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.
    van Trommel NE; Massuger LF; Schijf CP; ten Kate-Booij MJ; Sweep FC; Thomas CM
    J Clin Oncol; 2006 Jan; 24(1):52-8. PubMed ID: 16382113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human chorionic gonadotropin as a model for a fetal antigen.
    Bagshawe KD
    Ciba Found Symp; 1983; 96():146-59. PubMed ID: 6303723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for trophoblastic neoplasms in the Philippines.
    Gonzales RB
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):669-74. PubMed ID: 3012792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.